Research News and Research

RSS

University of Nevada researcher to optimize new rapid test for melioidosis

A new rapid test to diagnose melioidosis, a difficult infection to treat - and classified as a biothreat by the Centers for Disease Control and Prevention - is being optimized and tested by University of Nevada School of Medicine researcher David AuCoin.

9 Aug 2012

Viewpoints: Dubious ad on Romney's role in cancer death; British health plan has problems of its own

He sits at a kitchen table, nursing a cup of coffee, talking about what happened after Bain Capital closed down his steel plant in 2001. He lost his job; his family lost its health insurance. His wife felt lousy but didn't go to the doctor, to spare the family worry and expense. When she finally ended up in the hospital, the diagnosis was cancer. She had 22 days to live.

9 Aug 2012

Researchers develop and test new prostate cancer screening method

Researchers have successfully developed and tested a new prostate cancer screening method that uses the combined power of a novel drug therapy and changes in PSA levels over time to identify men with a high PSA who are more likely to have aggressive prostate cancer despite negative biopsies.

9 Aug 2012

Advocacy groups warn Trans-Pacific Partnership could affect access to low-cost medications, Bloomberg reports

Bloomberg Businessweek examines how ongoing trade negotiations related to the Trans-Pacific Partnership could affect access to quality low-cost medications, including antiretrovirals, in low- and middle-income countries. "Protecting the patents of drug makers ... as part of the Trans-Pacific Partnership has drawn criticism from groups such as Doctors Without Borders and Public Citizen," and "the proposed accord has also spurred calls from U.S. lawmakers for greater transparency about the negotiations," the news service writes.

9 Aug 2012

New England Biolabs releases Q5 High-Fidelity DNA Polymerase

New England Biolabs (NEB) has released a novel DNA polymerase, Q5 High-Fidelity DNA Polymerase, that provides the highest fidelity amplification currently available, while also offering robust amplification across the broadest range of amplicons, including those that are GC- and AT-rich.

From New England Biolabs 9 Aug 2012

The ALS Association announces new grants to support research on Lou Gehrig's Disease

The ALS Association announced today its latest research awards that include funding commitments of $4 million to researchers in 31 laboratories in the United States, United Kingdom, Belgium, Germany and Canada. These awards are part of its Translational Research Advancing Therapies for ALS (TREAT ALS™) program, through which The Association funds a diverse portfolio of research to find treatments and a cure for Lou Gehrig's Disease.

9 Aug 2012

New report examines detrimental impact of building materials and products on asthma

Leading global interdisciplinary design firm Perkins+Will today released a new report examining the detrimental impact of building materials and products on asthma.

9 Aug 2012

Educational programs, increased physician collaboration can reduce inappropriate CCTA use

Appropriate use of testing is a hot topic in medicine as physicians and hospitals look for ways to improve quality while containing cost to achieve high-value care. This is especially true in the field of cardiology where the potential consequences of incorrect diagnosis have led to overuse of cardiovascular imaging with CT scanners, called coronary CT angiography.

9 Aug 2012

One third of all post-partum women exhibit some symptoms of PTSD

Post-Traumatic Stress Disorder (PTSD) develops in individuals who experience highly traumatizing situations such as terrorist attacks and car accidents, but symptoms can also come about after normal life events - including childbirth.

9 Aug 2012

Amgen announces decision to stop ganitumab Phase 3 trial in advanced pancreatic cancer

Amgen today announced a decision to stop the ganitumab (AMG 479) Phase 3 GAMMA (Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas) trial following the recommendation of an independent Data Monitoring Committee (DMC) overseeing the trial.

9 Aug 2012

Lightlake announces final data from naloxone nasal spray Phase II study on Binge Eating Disorder

Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today compelling final data from a Phase II study of the Company's proprietary opioid antagonist naloxone nasal spray treatment for patients with Binge Eating Disorder (BED).

9 Aug 2012

Roundup: Seeking medical malpractice alternatives part of Mass. cost control law; Low-Income Health Program signs up 400k in Calif.

It may not seem like big news, but if you've followed the long-running, stubborn and mostly dug-in debate over reforming medical malpractice in the U.S., you know that when doctors and lawyers issue a joint news release, something is really going on. ... Formally, it's called "Disclosure, Apology and Offer" and it's a key provision of the new state health cost law. Massachusetts doctors and lawyers have agreed to work side by side on this less hostile (and potentially cost-saving) approach to dealing with medical errors and malpractice.

9 Aug 2012

Research News and Research

University of Nevada researcher to optimize new rapid test for melioidosis

Viewpoints: Dubious ad on Romney's role in cancer death; British health plan has problems of its own

Researchers develop and test new prostate cancer screening method

Advocacy groups warn Trans-Pacific Partnership could affect access to low-cost medications, Bloomberg reports

New England Biolabs releases Q5 High-Fidelity DNA Polymerase

The ALS Association announces new grants to support research on Lou Gehrig's Disease

New report examines detrimental impact of building materials and products on asthma

Educational programs, increased physician collaboration can reduce inappropriate CCTA use

One third of all post-partum women exhibit some symptoms of PTSD

Amgen announces decision to stop ganitumab Phase 3 trial in advanced pancreatic cancer

Lightlake announces final data from naloxone nasal spray Phase II study on Binge Eating Disorder

Roundup: Seeking medical malpractice alternatives part of Mass. cost control law; Low-Income Health Program signs up 400k in Calif.

VEGF inhibitor fails to improve nonsquamous NSCLC overall survival

Increases in NSCLC survival 'an artefact of PET assessment'

Lung cancer patients can be screened for ALK-inhibitor suitability

Elderly NSC lung cancer patients benefit from concurrent chemoradiation

Immigration influences HIV diagnosis demographics

Ischemic lesions signal preventive needs in ICH patients

Vulvodynia confers risk for other chronic pain syndromes

Old cardiac drug performs new tricks

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery